Skip to main content
Clinical Trials/NCT02185495
NCT02185495
Unknown
Phase 2

Screening and Diagnosing for Early Lung Cancer in Shanghai Communities With Imaging Procedures

Shanghai Changzheng Hospital1 site in 1 country3,000 target enrollmentJuly 2014
ConditionsLung Cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Shanghai Changzheng Hospital
Enrollment
3000
Locations
1
Primary Endpoint
The sensitivities of low-dose computed tomography and low-dose computed tomography with computer aided detection in detecting early lung cancer
Last Updated
11 years ago

Overview

Brief Summary

Imaging procedures including chest X-ray and low-dose computed tomography may be effective in lung cancer early detection. Yet it is unknown whether low-dose computed tomography combined with computer aided detection (CAD) is more effective than LDCT in screening of early lung cancer.

Detailed Description

The randomized clinical trial is to investigate and compare the effectiveness of CAD-guided low-dose computed tomography and low-dose computed tomography in lung cancer screening for community individuals in Shanghai, China. Thus, an imaging protocol which can detect early lung cancer in asymptomatic high risk patients will be proposed.

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
September 2017
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Liu ShiYuan

Shanghai Changzheng Hospital

Shanghai Changzheng Hospital

Eligibility Criteria

Inclusion Criteria

  • Age of 55 to 74 years; smoking history of at least 30 pack-years; and if former smoker, have quit within 15 years
  • Age 50 or older ,20 or more pack-year history of smoking, and one additional risk factor (occupational exposure, residential radon exposure, cancer history, family history of lung cancer, history of lung disease)
  • Age 35 and one additional risk factor
  • Ability to accept LDCT examination and sign informed consent form

Exclusion Criteria

  • Individuals with any symptoms suggestive of lung cancer (e.g., vigorous coughing, chest pain, weight loss, blood-stained sputum)
  • Individuals with acute pulmonary abnormalities or those in poor health conditions or those have metallic implants or devices in the chest or back will be excluded due to the potential impact on the results as well as difficulty of acquiring the images.
  • Pregnant women

Outcomes

Primary Outcomes

The sensitivities of low-dose computed tomography and low-dose computed tomography with computer aided detection in detecting early lung cancer

Time Frame: 24months

A questionaire will be recorded for each subject, including demographics, smoking history and disease history, etc. If a pulmonary nodule was found, the location, shape, size, margin and density will be recorded. A subject with a suspected malignant nodule, which was detected either by a radiologist or computed-aiding detection software, will refer to a physician for further management. Finally, the sensitivities of radiologist or software detection will be calculated.

Secondary Outcomes

  • The false positive rates between low-dose computed tomography and low-dose computed tomography with computer aided detection will be compared(24months)
  • Nodule detection rate(6 months)

Study Sites (1)

Loading locations...

Similar Trials